Selenium modifies the osteoblast inflammatory stress response to bone metastatic breast cancer

被引:51
作者
Chen, Yu-Chi [1 ]
Sosnoski, Donna M. [1 ]
Gandhi, Ujjawal H. [2 ]
Novinger, Leah J. [1 ]
Prabhu, K. Sandeep [2 ]
Mastro, Andrea M. [1 ]
机构
[1] Penn State Univ, Dept Biochem & Mol Biol, University Pk, PA 16802 USA
[2] Penn State Univ, Dept Vet & Biomed Sci, University Pk, PA 16802 USA
基金
美国国家卫生研究院;
关键词
NF-KAPPA-B; HUMAN PROSTATE-CANCER; METHYLSELENINIC ACID; GLUTATHIONE-PEROXIDASE; VITAMIN-E; IN-VIVO; PREVENTION; CELLS; MACROPHAGES; ACTIVATION;
D O I
10.1093/carcin/bgp227
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Breast cancer frequently metastasizes to the skeleton resulting in bone degradation due to osteoclast activation. Metastases also downregulate differentiation and the bone-rebuilding function of osteoblasts. Moreover, cancer cells trigger osteoblast inflammatory stress responses. Pro-inflammatory mediators such as interleukin (IL)-6, monocyte chemoattractant protein-1 (MCP-1), cyclooxygenase-2 (COX-2) and inducible nitric oxide synthase (iNOS), expressed by osteoblasts (MC3T3-E1) stimulated with human breast cancer cell (MDA-MB-231) conditioned medium, are pivotal to osteoclast activation and metastasis. Given that these genes are regulated by nuclear factor-kappa B (NF-kappa B), a redox-sensitive transcription factor, we hypothesized that selenium (Se) could abrogate the inflammatory response to metastatic breast cancer cells by modulating NF-kappa B. Caffeic acid phenethyl ester and parthenolide inhibited NF-kappa B activation, as seen by gel shift assays and immunoblotting for p65 in nuclear fractions, as well as decreased production of IL-6 and MCP-1. Supplementation of MC3T3-E1 with methylseleninic acid (MSA) (0.5 mu M to 4 mu M) reduced the activation of NF-kappa B leading to a decrease in IL-6, MCP-1, COX-2 and iNOS in response to MDA-MB-231 conditioned medium. Addition of MSA to osteoblasts for as little as 15 min suppressed activation of NF-kappa B suggesting that short-lived active metabolites might be involved. However, brief exposure to MSA also brought about an increase in selenoprotein glutathione peroxidase 1. In summary, our data indicate that the osteoblast response to metastatic breast cancer cells is regulated by NF-kappa B activation, which can be effectively suppressed by MSA either through short-lived active metabolites and/or selenoproteins. Thus, Se supplementation may prevent the osteoblast inflammatory response or dampen the vicious cycle established when breast cancer cells, osteoblasts and osteoclasts interact.
引用
收藏
页码:1941 / 1948
页数:8
相关论文
共 52 条
[1]   Models, mechanisms and clinical evidence for cancer dormancy [J].
Aguirre-Ghiso, Julio A. .
NATURE REVIEWS CANCER, 2007, 7 (11) :834-846
[2]   Cancer - An inflammatory link [J].
Balkwill, F ;
Coussens, LM .
NATURE, 2004, 431 (7007) :405-406
[3]   OPINION Is NF-κB a good target for cancer therapy? Hopes and pitfalls [J].
Baud, Veronique ;
Karin, Michael .
NATURE REVIEWS DRUG DISCOVERY, 2009, 8 (01) :33-40
[4]   HUMAN THIOREDOXIN REDUCTASE DIRECTLY REDUCES LIPID HYDROPEROXIDES BY NADPH AND SELENOCYSTINE STRONGLY STIMULATES THE REACTION VIA CATALYTICALLY GENERATED SELENOLS [J].
BJORNSTEDT, M ;
HAMBERG, M ;
KUMAR, S ;
XUE, J ;
HOLMGREN, A .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (20) :11761-11764
[5]   The bone microenvironment in metastasis; what is special about bone? [J].
Bussard, Karen M. ;
Gay, Carol V. ;
Mastro, Andrea M. .
CANCER AND METASTASIS REVIEWS, 2008, 27 (01) :41-55
[6]   BREAST TUMOR-CELL LINES FROM PLEURAL EFFUSIONS [J].
CAILLEAU, R ;
YOUNG, R ;
OLIVE, M ;
REEVES, WJ .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1974, 53 (03) :661-674
[7]   Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin a randomized controlled trial - A randomized controlled trial [J].
Clark, LC ;
Combs, GF ;
Turnbull, BW ;
Slate, EH ;
Chalker, DK ;
Chow, J ;
Davis, LS ;
Glover, RA ;
Graham, GF ;
Gross, EG ;
Krongrad, A ;
Lesher, JL ;
Park, HK ;
Sanders, BB ;
Smith, CL ;
Taylor, JR .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1996, 276 (24) :1957-1963
[8]   An analysis of cancer prevention by selenium [J].
Combs, GF ;
Clark, LC ;
Turnbull, BW .
BIOFACTORS, 2001, 14 (1-4) :153-159
[9]   SERUM BONE GAMMA-CARBOXYGLUTAMIC ACID CONTAINING PROTEIN IN PRIMARY HYPERPARATHYROIDISM AND IN MALIGNANT HYPERCALCEMIA - COMPARISON WITH BONE HISTOMORPHOMETRY [J].
DELMAS, PD ;
DEMIAUX, B ;
MALAVAL, L ;
CHAPUY, MC ;
EDOUARD, C ;
MEUNIER, PJ .
JOURNAL OF CLINICAL INVESTIGATION, 1986, 77 (03) :985-991
[10]  
Duffield-Lillico AJ, 2002, CANCER EPIDEM BIOMAR, V11, P630